Industry News
Wyatt Technology to host this year’s International Light Scattering Colloquium
The 22nd Annual International Light Scattering Colloquium will be held at the Four Seasons Biltmore Resort in Santa Barbara, California.
[ + ]Trials one step closer to treating Duchenne Muscular Dystrophy
Clinical trials have successfully administered the compound AVI-4658, designed to restore dystrophin expression in participants with Duchenne Muscular Dystrophy.
[ + ]Macquarie Uni student helps discover new planetary nebula
Macquarie University PhD student Dimitri Douchin has helped discover a new planetary nebula in our Milky Way.
[ + ]Feature: Biosecurity and animal-borne viruses
CSIRO’s Dr Lin-Fa Wang works in the depths of a national biosecurity facility jam-packed with some of the planet’s nastier viruses that call bats home. [ + ]
Feature: Battling Hendra virus
Over the last 15 years, Dr Lin-Fa Wang ‘s group has quadrupled in size and now works on many different aspects of bat biology. [ + ]
Feature: Biosecurity batman
CSIRO's Dr Lin-Fa Wang is investigating viruses in bats in the hope of finding insights into how they spread to humans. [ + ]
Uni of Qld to acquire powerful MRI
The University of Queensland has entered into an agreement with technology specialist Siemens to install a powerful MRI system.
[ + ]Feature: Sequencing 3.0
The Institute for Molecular Biosciences' Sean Grimmond is the first in Australia to get hands on experience using the next next generation Ion Torrent technology. [ + ]
New hope for treatment of Ross River fever
A discovery by scientists at Griffith University’s Institute for Glycomics opens the possibility of a new treatment for viruses that cause inflammation, such as Ross River virus and Dengue Fever. [ + ]
Sydney and UK researchers gang up on malaria
Researchers from Sydney and the UK are partnering to understand why malaria can be fatal to some but milder in others. [ + ]
Ian Frazer partners with US university on DNA vaccine
Coridon and Ohio State University have begun collaborating on testing Coridon’s DNA vaccine for Epstein Barr Virus for the prevention of lymphoproliferative disease. [ + ]
